Submitted by Anonymous (not verified) on 24 April 2024 - 16:51
Human medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 7, Status: Authorised